A single dose study evaluating the effect of food on the pharmacokinetics of raltegravir under fed (low- and high-fat) and fasted conditions in healthy volunteers

Trial Profile

A single dose study evaluating the effect of food on the pharmacokinetics of raltegravir under fed (low- and high-fat) and fasted conditions in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jan 2017

At a glance

  • Drugs Raltegravir (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 07 Dec 2013 New trial record
    • 16 Oct 2013 Results will be presented at the 14th European AIDS Conference (EACS), according to a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top